Rehabilitation Is Associated With Improvements in Post-COVID-19 Sequelae.

IF 2.4 4区 医学 Q2 CRITICAL CARE MEDICINE
Andreas Asimakos, Stavroula Spetsioti, Spyros Mentzelopoulos, Ioannis Vogiatzis, Alice G Vassiliou, Pantelis Gounopoulos, Archontoula Antonoglou, Dimitrios Spaggoulakis, Sofia Pappa, Spyros Zakynthinos, Ioanna Dimopoulou, Paraskevi Katsaounou
{"title":"Rehabilitation Is Associated With Improvements in Post-COVID-19 Sequelae.","authors":"Andreas Asimakos, Stavroula Spetsioti, Spyros Mentzelopoulos, Ioannis Vogiatzis, Alice G Vassiliou, Pantelis Gounopoulos, Archontoula Antonoglou, Dimitrios Spaggoulakis, Sofia Pappa, Spyros Zakynthinos, Ioanna Dimopoulou, Paraskevi Katsaounou","doi":"10.4187/respcare.11863","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Post-COVID-19 syndrome has affected millions of people, with rehabilitation being at the center of non-pharmacologic care. However, numerous published studies show conflicting results due to, among other factors, considerable variation in subject characteristics. Currently, the effects of age, sex, time of implementation, and prior disease severity on the outcomes of a supervised rehabilitation program after COVID-19 remain unknown.</p><p><strong>Methods: </strong>This was a non-randomized case-control study. Subjects with post-COVID-19 sequelae were enrolled. Among study participants, those who could attend an 8-week, supervised rehabilitation program composed the intervention group, whereas those who couldn't the control group. Measurements were collected at baseline and 8 weeks thereafter.</p><p><strong>Results: </strong>Study groups (<i>N</i> = 119) had similar baseline measurements. Participation in rehabilitation (<i>n</i> = 47) was associated with clinically important improvements in the 6-min walk test (6MWT) distance, adjusted (for potential confounders) odds ratio (AOR) 4.56 (95% CI 1.95-10.66); 1-min sit-to-stand test, AOR 4.64 (1.88-11.48); Short Physical Performance Battery, AOR 7.93 (2.82-22.26); health-related quality of life (HRQOL) 5-level EuroQol-5D (Visual Analog Scale), AOR 3.12 (1.37-7.08); Montreal Cognitive Assessment, AOR 6.25 (2.16-18.04); International Physical Activity Questionnaire, AOR 3.63 (1.53-8.59); Fatigue Severity Scale, AOR 4.07 (1.51-10.98); Chalder Fatigue Scale (bimodal score), AOR 3.33 (1.45-7.67); Modified Medical Research Council dyspnea scale (mMRC), AOR 4.43 (1.83-10.74); Post-COVID-19 Functional Scale (PCFS), AOR 3.46 (1.51-7.95); and COPD Assessment Test, AOR 7.40 (2.92-18.75). Time from disease onset was marginally associated only with 6MWT distance, AOR 0.99 (0.99-1.00). Prior hospitalization was associated with clinically important improvements in the mMRC dyspnea scale, AOR 3.50 (1.06-11.51); and PCFS, AOR 3.42 (1.16-10.06). Age, sex, and ICU admission were not associated with the results of any of the aforementioned tests/grading scales.</p><p><strong>Conclusions: </strong>In this non-randomized, case-control study, post-COVID-19 rehabilitation was associated with improvements in physical function, activity, HRQOL, respiratory symptoms, fatigue, and cognitive impairment. These associations were observed independently of timing of rehabilitation, age, sex, prior hospitalization, and ICU admission.</p>","PeriodicalId":21125,"journal":{"name":"Respiratory care","volume":" ","pages":"1361-1370"},"PeriodicalIF":2.4000,"publicationDate":"2024-10-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11549631/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Respiratory care","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.4187/respcare.11863","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CRITICAL CARE MEDICINE","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Post-COVID-19 syndrome has affected millions of people, with rehabilitation being at the center of non-pharmacologic care. However, numerous published studies show conflicting results due to, among other factors, considerable variation in subject characteristics. Currently, the effects of age, sex, time of implementation, and prior disease severity on the outcomes of a supervised rehabilitation program after COVID-19 remain unknown.

Methods: This was a non-randomized case-control study. Subjects with post-COVID-19 sequelae were enrolled. Among study participants, those who could attend an 8-week, supervised rehabilitation program composed the intervention group, whereas those who couldn't the control group. Measurements were collected at baseline and 8 weeks thereafter.

Results: Study groups (N = 119) had similar baseline measurements. Participation in rehabilitation (n = 47) was associated with clinically important improvements in the 6-min walk test (6MWT) distance, adjusted (for potential confounders) odds ratio (AOR) 4.56 (95% CI 1.95-10.66); 1-min sit-to-stand test, AOR 4.64 (1.88-11.48); Short Physical Performance Battery, AOR 7.93 (2.82-22.26); health-related quality of life (HRQOL) 5-level EuroQol-5D (Visual Analog Scale), AOR 3.12 (1.37-7.08); Montreal Cognitive Assessment, AOR 6.25 (2.16-18.04); International Physical Activity Questionnaire, AOR 3.63 (1.53-8.59); Fatigue Severity Scale, AOR 4.07 (1.51-10.98); Chalder Fatigue Scale (bimodal score), AOR 3.33 (1.45-7.67); Modified Medical Research Council dyspnea scale (mMRC), AOR 4.43 (1.83-10.74); Post-COVID-19 Functional Scale (PCFS), AOR 3.46 (1.51-7.95); and COPD Assessment Test, AOR 7.40 (2.92-18.75). Time from disease onset was marginally associated only with 6MWT distance, AOR 0.99 (0.99-1.00). Prior hospitalization was associated with clinically important improvements in the mMRC dyspnea scale, AOR 3.50 (1.06-11.51); and PCFS, AOR 3.42 (1.16-10.06). Age, sex, and ICU admission were not associated with the results of any of the aforementioned tests/grading scales.

Conclusions: In this non-randomized, case-control study, post-COVID-19 rehabilitation was associated with improvements in physical function, activity, HRQOL, respiratory symptoms, fatigue, and cognitive impairment. These associations were observed independently of timing of rehabilitation, age, sex, prior hospitalization, and ICU admission.

康复治疗有助于改善 COVID-19 后遗症。
背景:后 COVID-19 综合征影响了数百万人,康复治疗是非药物治疗的核心。然而,由于受试者特征的巨大差异等因素,许多已发表的研究结果相互矛盾。目前,年龄、性别、实施时间和先前疾病严重程度对 COVID-19 后监督康复计划结果的影响仍然未知:这是一项非随机病例对照研究。方法:这是一项非随机病例对照研究,研究对象为 COVID-19 后遗症患者。在研究参与者中,能参加为期 8 周的监督康复计划的人为干预组,不能参加的人为对照组。在基线和之后的 8 周收集测量数据:研究组(119 人)的基线测量结果相似。参加康复训练(n = 47)与 6 分钟步行测试(6MWT)距离的临床重要改善有关,调整后(针对潜在混杂因素)的几率比(AOR)为 4.56(95% CI 1.95-10.66);1 分钟坐立测试,AOR 4.64(1.88-11.48);短期体能测试,AOR 7.93(2.82-22.26);健康相关生活质量(HRQOL)5 级 EuroQol-5D(视觉模拟量表),AOR 3.12(1.37-7.08); Montreal Cognitive Assessment, AOR 6.25 (2.16-18.04); International Physical Activity Questionnaire, AOR 3.63 (1.53-8.59); Fatigue Severity Scale, AOR 4.07 (1.51-10.98); Chalder Fatigue Scale (bimodal score), AOR 3.33(1.45-7.67);改良医学研究委员会呼吸困难量表(mMRC),AOR 4.43(1.83-10.74);COVID-19 后功能量表(PCFS),AOR 3.46(1.51-7.95);COPD 评估测试,AOR 7.40(2.92-18.75)。发病时间仅与 6MWT 距离略有关联,AOR 为 0.99(0.99-1.00)。之前的住院治疗与 mMRC 呼吸困难量表(AOR 3.50 (1.06-11.51))和 PCFS(AOR 3.42 (1.16-10.06))的临床重要改善相关。年龄、性别和入住 ICU 与上述任何测试/评分量表的结果均无关联:在这项非随机病例对照研究中,COVID-19 后康复治疗与身体功能、活动、HRQOL、呼吸道症状、疲劳和认知障碍的改善有关。这些关联的观察与康复时间、年龄、性别、之前的住院治疗和入住 ICU 无关。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Respiratory care
Respiratory care 医学-呼吸系统
CiteScore
4.70
自引率
16.00%
发文量
209
审稿时长
1 months
期刊介绍: RESPIRATORY CARE is the official monthly science journal of the American Association for Respiratory Care. It is indexed in PubMed and included in ISI''s Web of Science.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信